tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co (JP:4536)
:4536
Japanese Market

Santen Pharmaceutical Co (4536) Ratios

Compare
0 Followers

Santen Pharmaceutical Co Ratios

JP:4536's free cash flow for Q3 2024 was ¥0.55. For the 2024 fiscal year, JP:4536's free cash flow was decreased by ¥ and operating cash flow was ¥0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
2.54 2.38 2.39 2.63 3.23
Quick Ratio
2.08 1.94 2.01 2.10 2.71
Cash Ratio
1.02 0.65 0.87 0.80 1.35
Solvency Ratio
0.34 0.02 0.36 0.26 0.38
Operating Cash Flow Ratio
0.78 0.42 0.48 0.49 0.59
Short-Term Operating Cash Flow Coverage
26.44 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 105.81B¥ 85.44B¥ 106.29B¥ 110.93B¥ 112.35B
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.09 0.07 0.03 0.03
Debt-to-Equity Ratio
0.11 0.12 0.10 0.03 0.04
Debt-to-Capital Ratio
0.10 0.11 0.09 0.03 0.04
Long-Term Debt-to-Capital Ratio
0.08 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
1.42 1.43 1.36 1.31 1.35
Debt Service Coverage Ratio
9.85 3.41 38.13 16.29 16.31
Interest Coverage Ratio
14.47 -2.06 29.68 8.68 14.01
Debt to Market Cap
0.06 0.00 0.00 0.00 <0.01
Interest Debt Per Share
103.09 97.33 85.40 29.12 36.88
Net Debt to EBITDA
-1.05 -1.52 -0.92 -1.76 -1.60
Profitability Margins
Gross Profit Margin
54.27%59.52%58.81%60.65%60.74%
EBIT Margin
10.78%-1.54%13.83%4.84%14.28%
EBITDA Margin
18.70%5.12%20.48%12.02%20.46%
Operating Profit Margin
12.76%-1.11%13.48%5.17%13.88%
Pretax Profit Margin
9.89%-2.08%13.38%4.98%13.29%
Net Profit Margin
8.82%-5.36%10.22%2.74%9.78%
Continuous Operations Profit Margin
8.84%-5.37%10.21%3.66%8.99%
Net Income Per EBT
89.18%257.77%76.42%55.00%73.60%
EBT Per EBIT
77.51%187.67%99.25%96.14%95.69%
Return on Assets (ROA)
6.11%-3.55%5.92%1.70%5.78%
Return on Equity (ROE)
8.70%-5.08%8.06%2.22%7.80%
Return on Capital Employed (ROCE)
11.24%-0.93%9.85%3.99%9.83%
Return on Invested Capital (ROIC)
9.97%-2.41%7.52%2.13%6.65%
Return on Tangible Assets
7.57%-4.60%8.25%2.36%8.17%
Earnings Yield
5.11%-3.41%5.55%1.12%3.18%
Efficiency Ratios
Receivables Turnover
3.34 2.60 2.67 2.60 2.78
Payables Turnover
5.74 4.47 4.49 4.05 4.33
Inventory Turnover
3.20 2.87 2.95 2.36 2.69
Fixed Asset Turnover
4.22 4.22 4.73 6.32 6.79
Asset Turnover
0.69 0.66 0.58 0.62 0.59
Working Capital Turnover Ratio
2.26 2.17 2.04 1.79 1.69
Cash Conversion Cycle
160.04 185.65 178.86 204.72 183.02
Days of Sales Outstanding
109.44 140.18 136.52 140.37 131.46
Days of Inventory Outstanding
114.15 127.17 123.61 154.50 135.80
Days of Payables Outstanding
63.55 81.70 81.27 90.15 84.24
Operating Cycle
223.59 267.35 260.14 294.87 267.26
Cash Flow Ratios
Operating Cash Flow Per Share
198.01 95.88 115.17 97.15 100.08
Free Cash Flow Per Share
168.88 32.42 25.52 37.56 76.96
CapEx Per Share
29.13 63.47 89.65 59.59 23.12
Free Cash Flow to Operating Cash Flow
0.85 0.34 0.22 0.39 0.77
Dividend Paid and CapEx Coverage Ratio
3.22 1.00 0.96 1.11 2.04
Capital Expenditure Coverage Ratio
6.80 1.51 1.28 1.63 4.33
Operating Cash Flow Coverage Ratio
2.07 1.03 1.40 3.82 3.24
Operating Cash Flow to Sales Ratio
0.24 0.13 0.17 0.16 0.17
Free Cash Flow Yield
11.89%2.87%2.08%2.47%4.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.55 -29.29 18.02 89.07 31.40
Price-to-Sales (P/S) Ratio
1.73 1.57 1.84 2.44 3.07
Price-to-Book (P/B) Ratio
1.70 1.49 1.45 1.98 2.45
Price-to-Free Cash Flow (P/FCF) Ratio
8.41 34.86 48.08 40.55 24.14
Price-to-Operating Cash Flow Ratio
7.17 11.79 10.65 15.68 18.57
Price-to-Earnings Growth (PEG) Ratio
-0.07 0.19 0.06 -1.25 -1.27
Price-to-Fair Value
1.70 1.49 1.45 1.98 2.45
Enterprise Value Multiple
8.18 29.10 8.08 18.52 13.41
EV to EBITDA
8.18 29.10 8.08 18.52 13.41
EV to Sales
1.53 1.49 1.65 2.23 2.74
EV to Free Cash Flow
7.45 33.13 43.17 37.03 21.57
EV to Operating Cash Flow
6.35 11.20 9.57 14.32 16.59
Tangible Book Value Per Share
603.86 489.40 482.55 418.86 402.31
Shareholders’ Equity Per Share
834.19 758.81 844.19 770.01 758.76
Tax and Other Ratios
Effective Tax Rate
0.11 -1.58 0.24 0.46 0.32
Revenue Per Share
823.04 720.24 666.02 624.86 605.16
Net Income Per Share
72.62 -38.58 68.08 17.10 59.17
Tax Burden
0.89 2.58 0.76 0.55 0.74
Interest Burden
0.92 1.35 0.97 1.03 0.93
Research & Development to Revenue
0.08 0.10 0.10 0.10 0.10
SG&A to Revenue
0.30 0.34 0.32 0.32 0.30
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.72 -2.48 1.69 5.84 1.84
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis